278. Huge lymphatic malformation with cervicofacial lesion
19 clinical trials, 23 drugs (DrugBank: 7 drugs), 5 drug target genes, 62 drug target pathways
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00010452 (ClinicalTrials.gov) | April 2000 | 2/2/2001 | Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations | Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial | Lymphatic Malformations | Drug: picibanil | University of Iowa | NULL | Completed | 6 Months | 18 Years | Both | 150 | Phase 2;Phase 3 | United States |
| 2 | NCT03427619 (ClinicalTrials.gov) | January 1, 1998 | 10/1/2018 | OK432 (Picibanil) in the Treatment of Lymphatic Malformations | OK432 (Picibanil) in the Treatment of Lymphatic Malformations | Lymphatic Malformations | Drug: OK432 | Richard JH Smith | NULL | Completed | 6 Months | 17 Years | All | 701 | Phase 4 | United States |